IBN Initiates Coverage of Soligenix Inc.
AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on ...
Investornewsbreaks Soligenix Inc. (NASDAQ: SNGX) Taps IBN To Lead Corporate Communications Strategy
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications an ...
Soligenix Announces Publication Demonstrating Civaxtm Booster Induces Rapid Broad Protection Against COVID-19 Variants
Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...